Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Revenue (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of Revenue data on record, last reported at $172000.0 in Q1 2025.

  • For Q1 2025, Revenue changed N/A year-over-year to $172000.0; the TTM value through Sep 2025 reached $1.2 million, up 192.59%, while the annual FY2024 figure was $1.0 million, N/A changed from the prior year.
  • Revenue reached $172000.0 in Q1 2025 per RANI's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Revenue topped out at $2.0 million in Q2 2021 and bottomed at -$1.3 million in Q3 2023.
  • Average Revenue over 5 years is -$168888.9, with a median of -$352000.0 recorded in 2022.
  • Peak YoY movement for Revenue: tumbled 273.86% in 2023, then surged 179.32% in 2024.
  • A 5-year view of Revenue shows it stood at $2.0 million in 2021, then tumbled by 117.95% to -$352000.0 in 2022, then tumbled by 268.18% to -$1.3 million in 2023, then soared by 179.32% to $1.0 million in 2024, then crashed by 83.27% to $172000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $172000.0 in Q1 2025, $1.0 million in Q4 2024, and -$1.3 million in Q4 2023.